Domen Ribnikar (Author), Špela Fink (Author), Snježana Frković-Grazio (Author), Hotimir Lešničar (Author), Aleksander Sadikov (Author), Tanja Čufer (Author)

Abstract

Potek bolezni pri bolnicah s HER-2 pozitivnim rakom dojk

Keywords

No keyword data available

Data

Language: Slovenian
Year of publishing:
Typology: 1.01 - Original Scientific Article
Organization: OI - Institute of Oncology
UDC: 616-006
COBISS: 25343193 Link will open in a new window
ISSN: 1408-1741
Parent publication: Onkologija
Views: 2257
Downloads: 537
Average score: 0 (0 votes)
Metadata: JSON JSON-RDF JSON-LD TURTLE N-TRIPLES XML RDFA MICRODATA DC-XML DC-RDF RDF

Other data

Secondary language: English
Secondary title: Clinical course of HER-2 positive breast cancer patients
Secondary abstract: Breast cancer is the most frequent cancer in women. The course and efficiency of breast cancer treatment are influenced by several factors. The expression of HER-2 protein and HER-2 gene is gaining in strength in breast cancer management. The aim of our study was to compare the course of HER-2 positive with HER-2 negative disease. In median time of 2.5 years DFS (disease-free-survival) of patients with HER-2 positive tumours was 76.1%, and 93.4% for patients with HER-2 negative disease. HER-2 status was the strongest prognostic factor for DFS (p
Secondary keywords: Breast Neoplasms;Genetics;Neoplasm Staging;Genes, Erbb-2;Survival Analysis;Disease-Free Survival;Retrospective Studies;Preživetje, analiza;Brez bolezni, preživetje;Dojka, novotvorbe;Geni erB-2;Novotvorba, stadij;Retrospektivne študije;
URN: URN:NBN:SI
Source comment: Soavtorji: Š. Fink, S. Frković Grazio, H. Lešničar, A. Sadikov in T. Čufer; BSDOCID143369;
Pages: str. 94-98
Volume: ǂLetn. ǂ12
Issue: ǂšt. ǂ2
Chronology: 2008
ID: 10957171